Ganirelix Acetate
Active substance: Ganirelix
INJECTION · GANIRELIX ACETATE 250 ug/.5mL
United StatesActive
Marketing holder: Xiromed LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- GANIRELIX ACETATE · 250 ug/.5mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 2 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2e90-7d87-9ca5-c6d122402abf,01a1208c-329a-7e73-9a30-a45c46e2642c,01a1208c-bb15-7535-b975-9cb0de376579,01a12092-8558-748a-afe4-b137a209e54c,01a12096-f4e6-7d47-b75b-a3f3387c7908;count=10 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70700-327
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 70700-327 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70700-327 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70700-327 · Verified 2026-10-09 · open in source